Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 9(6): e99809, 2014.
Article in English | MEDLINE | ID: mdl-24924588

ABSTRACT

The purpose of this study is to develop a mouse sperm preservation method based on evaporative drying. Mouse sperm were evaporatively dried and stored at 4°C and ambient temperature for 3 months to 2 years. Upon rehydration, a single sperm was injected into a mature oocyte to develop into a blastocyst after culture or a live birth after embryo transfer to a recipient female. For the samples stored at 4°C for 3, 6, 12, 18, and 24 months, the blastocyst formation rate was 61.5%, 49.1%, 31.5%, 32.2%, and 41.4%, respectively. The blastocyst rate for those stored at ambient temperature (∼22°C) for 3, 6, 12, and 18 months was 57.8%, 36.2%, 33.6%, and 34.4%, respectively. Fifteen, eight and three live pups were produced from sperm stored at room temperature for 12, 18, and 24 months, respectively. This is the first report of live offspring produced from dried mouse sperm stored at ambient temperature for up to 2 years. Based on these results, we suggest that evaporative drying is a potentially useful method for the routine preservation of mouse sperm.


Subject(s)
Desiccation , Live Birth , Semen Preservation/methods , Temperature , Animals , Animals, Newborn , Cells, Cultured , Embryo Transfer/veterinary , Female , Live Birth/veterinary , Male , Mice , Mice, Inbred C57BL , Mice, Inbred ICR , Pregnancy , Semen Preservation/veterinary , Sperm Injections, Intracytoplasmic/veterinary , Time Factors
2.
PLoS One ; 7(1): e29924, 2012.
Article in English | MEDLINE | ID: mdl-22272261

ABSTRACT

With the fast advancement in the genetics and bio-medical fields, the vast number of valuable transgenic and rare genetic mouse models need to be preserved. Preservation of mouse sperm by convective drying and subsequent storing at above freezing temperatures could dramatically reduce the cost and facilitate shipping. Mouse sperm were convectively dried under nitrogen gas in the Na-EGTA solution containing 100 mmol/L 3-O-methyl-D-glucose and stored in LiCl sorption jars (Relative Humidity, RH, 12%) at 4°C and 22°C for up to one year. The functionality of these sperm samples after storage was tested by intracytoplasmic injection into mouse oocytes. The percentages of blastocysts produced from sperm stored at 4°C for 1, 2, 3, 6, and 12 months were 62.6%, 53.4%, 39.6%, 33.3%, and 30.4%, respectively, while those stored at 22°C for 1, 2, and 3 months were 28.8%, 26.6%, and 12.2%, respectively. Transfer of 38 two- to four-cell embryos from sperm stored at 4°C for 1 year produced two live pups while 59 two- to four-cell embryos from sperm stored at 22°C for 3 months also produced two live pups. Although all the pups looked healthy at 3 weeks of age, normality of offspring produced using convectively dried sperm needs further investigation. The percentages of blastocyst from sperm stored in the higher relative humidity conditions of NaBr and MgCl(2) jars and driest condition of P(2)O(5) jars at 4°C and 22°C were all lower. A simple method of mouse sperm preservation is demonstrated. Three-O-methyl-D-glucose, a metabolically inactive derivative of glucose, offers significant protection for dried mouse sperm at above freezing temperatures without the need for poration of cell membrane.


Subject(s)
3-O-Methylglucose/pharmacology , Desiccation/methods , Semen Preservation/methods , Spermatozoa/drug effects , Animals , Animals, Newborn , Blastocyst , Embryo Transfer/methods , Embryo Transfer/statistics & numerical data , Female , Linear Models , Logistic Models , Male , Mice , Mice, Inbred ICR , Mice, Inbred Strains , Oocytes/cytology , Oocytes/growth & development , Sperm Injections, Intracytoplasmic/methods , Sperm Injections, Intracytoplasmic/statistics & numerical data , Spermatozoa/cytology , Temperature , Time Factors
3.
Biol Reprod ; 73(4): 627-33, 2005 Oct.
Article in English | MEDLINE | ID: mdl-15930320

ABSTRACT

Mouse sperm with and without trehalose were desiccated under nitrogen gas and stored at 4 degrees C and 22 degrees C. After rehydration, sperm were injected into oocytes using intracytoplasmic sperm injection and embryonic development was followed. Sperm were dried for 5.0, 6.25, or 7.5 min, stored at 22 degrees C for 1 wk with and without trehalose. The percentages of blastocysts that developed from sperm with trehalose were 51%, 31%, and 20%, respectively, which was significantly higher than sperm without trehalose (10%, 3%, and 5%, respectively). Desiccation and storage in medium with trehalose significantly increased sperm developmental potential compared to medium without trehalose. Sperm dried for 5 min produced more blastocysts than sperm dried for 6.25 or 7.5 min. When sperm were dried in trehalose for 5 min and stored for 1 wk, 2 wk, 1 mo, or 3 mo at 4 degrees C, the percentages of blastocysts were 73%, 84%, 63%, and 39%; whereas those stored at 22 degrees C for 1 wk, 2 wk, or 1 mo were significantly lower (53%, 17%, and 6%, respectively). Embryos from sperm partially desiccated in trehalose for 5 min and stored at 4 degrees C for 1 or 3 mo were transferred to 10 pseudopregnant recipients. Implantation rates were 81% and 48%; live fetuses were 26% and 5%, respectively. One of the recipients delivered three live fetuses. The results show that trehalose has a significant beneficial effect in preserving the developmental potential of mouse sperm following partial desiccation and storage at temperatures above freezing.


Subject(s)
Culture Media/chemistry , Desiccation/methods , Semen Preservation/methods , Spermatozoa/physiology , Trehalose , Animals , Blastocyst/drug effects , Blastocyst/physiology , Egtazic Acid , Female , Fertilization in Vitro/methods , Freezing , Kinetics , Male , Mice , Mice, Inbred Strains , Pregnancy , Pregnancy Outcome , Pregnancy Rate , Trehalose/pharmacology , Water
4.
Cryobiology ; 46(2): 121-34, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12686202

ABSTRACT

Sugars such as trehalose are effectively used by various organisms as protective agents to undergo anhydrobiosis and cryobiosis. The objective of this study was first to establish a method for quantitative delivery of trehalose as a model sugar into oocytes, and then to evaluate its effect on development of mouse zygotes. To this end, a quantitative microinjection technique was developed using volumetric response of microdroplets suspended in dimethylpolysilaxene. To verify accuracy of this technique, both microdroplets and oocytes were microinjected with fluorophore-labeled dextran. Thereafter, injection volumes were calculated from fluorescence intensity, and volumetric responses of both microdroplets and oocytes. Comparison of calculated injection volumes revealed that this technique reflects microinjection into oocytes with pL-accuracy. The next series of experiments focused on toxicity of injection buffers (i.e., 10mM Tris and 15mM Hepes) and trehalose. Microinjection of Hepes and Tris buffer in the presence of 0.1M trehalose resulted in blastocyst rates of 86 and 72%, respectively, without a significant difference when compared to controls (86%). In subsequent experiments, Hepes was used as the injection buffer, and embryonic development of zygotes was studied as a function of intracellular trehalose concentrations. Microinjection of trehalose up to 0.15M resulted in development to blastocyst stage similar to controls (85 and 87%, respectively) while the blastocyst rate was significantly decreased (43%) in the presence of 0.20M intracellular trehalose. When transferred to foster mothers, trehalose-injected zygotes (0.1M) implanted and developed to day 16 fetuses similar to controls, healthy pups were born. The findings of this study suggest that trehalose at effective intracellular concentrations does not impair development of mouse zygotes.


Subject(s)
Embryonic and Fetal Development/drug effects , Microinjections/methods , Oocytes/drug effects , Trehalose/pharmacology , Zygote/drug effects , Animals , Blastocyst/drug effects , Cryopreservation/methods , Cryoprotective Agents/administration & dosage , Cryoprotective Agents/pharmacology , Dose-Response Relationship, Drug , Embryo Transfer , Female , HEPES/administration & dosage , HEPES/toxicity , Male , Mice , Pregnancy , Trehalose/administration & dosage , Trehalose/adverse effects , Tromethamine/administration & dosage , Tromethamine/toxicity
5.
J Exp Med ; 196(11): 1497-506, 2002 Dec 02.
Article in English | MEDLINE | ID: mdl-12461084

ABSTRACT

Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF, VEGF-A) is a multifunctional cytokine with important roles in pathological angiogenesis. Using an adenoviral vector engineered to express murine VEGF-A(164), we previously investigated the steps and mechanisms by which this cytokine induced the formation of new blood vessels in adult immunodeficient mice and demonstrated that the newly formed blood vessels closely resembled those found in VEGF-A-expressing tumors. We now report that, in addition to inducing angiogenesis, VEGF-A(164) also induces a strong lymphangiogenic response. This finding was unanticipated because lymphangiogenesis has been thought to be mediated by other members of the VPF/VEGF family, namely, VEGF-C and VEGF-D. The new "giant" lymphatics generated by VEGF-A(164) were structurally and functionally abnormal: greatly enlarged with incompetent valves, sluggish flow, and delayed lymph clearance. They closely resembled the large lymphatics found in lymphangiomas/lymphatic malformations, perhaps implicating VEGF-A in the pathogenesis of these lesions. Whereas the angiogenic response was maintained only as long as VEGF-A was expressed, giant lymphatics, once formed, became VEGF-A independent and persisted indefinitely, long after VEGF-A expression ceased. These findings raise the possibility that similar, abnormal lymphatics develop in other pathologies in which VEGF-A is overexpressed, e.g., malignant tumors and chronic inflammation.


Subject(s)
Angiogenesis Inducing Agents/physiology , Endothelial Growth Factors/physiology , Intercellular Signaling Peptides and Proteins/physiology , Lymphatic System/pathology , Lymphokines/physiology , Neovascularization, Pathologic/etiology , Adenoviridae/genetics , Animals , Female , Lymphatic Metastasis , Lymphatic System/physiology , Lymphoma/etiology , Mice , Thymidine/metabolism , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factor Receptor-2/physiology , Vascular Endothelial Growth Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...